MGI(SH:688114) Zhi Tong Cai Jing·2026-01-12 01:04Group 1 - The AI healthcare sector has shown strong performance recently, driven by OpenAI's launch of ChatGPT Health and Ant Group's monthly active users surpassing 30 million, leading to a rally across the sector [1] - BGI Genomics (688114.SH), a leader in the upstream life sciences sector, has gained significant attention from the capital market, with a daily increase of 10.21% and a weekly increase of 23.4% as of last Friday's close [1] - BGI Genomics is leading in the "AI + gene sequencing" layout within the AI healthcare field, continuously upgrading its laboratory intelligent automation (GLI) business and accelerating the development of AI-driven software tools [1] Group 2 - According to a report by Grand View Research, the global AI healthcare market is projected to reach approximately $26.65 billion in 2024 and is expected to soar to about $505.59 billion by 2033, with a compound annual growth rate (CAGR) of 38.8% during this period [2] - BGI Genomics is expected to leverage its full industry chain layout to continuously release growth potential in the trillion-dollar AI healthcare sector, especially after being officially included in the CSI A500 Index on January 6 [2]